And to me, this captures in a nutshell why we are leading with the cuff based PULSE device. The clinic and medical fraternity isn't ready YET for cuffless blood pressure monitoring.
We can build a huge business with Pulse reading CBP/BP and biomarkers generated from data analysis of these readings, and how they interact.
CONNEQT Band is being worked on in earnest at CardieX, and if we are able to get FDA acceptance ( I honestly don't know what the primary predicate device would be for clearance rather than acceptance ... would PULSE qualify ? ), IMHO it would be a billion dollar business industry game changer.
CDX Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held
